Regulatory & Compliance

Unraveling a Fiscal Shift in Healthcare Funding In an era where state budgets are increasingly strained, the Centers for Medicare & Medicaid Services (CMS) dropped a seismic update on November 17, with preliminary guidance that reshapes the Medicaid funding landscape. Stemming from the One Big

In a remarkable stride forward for orthopedic surgery, Zimmer Biomet has secured pivotal approval from the U.S. Food and Drug Administration (FDA) for an enhanced version of its robotic knee surgery system, marking a significant leap in medical technology that promises to improve patient outcomes.

Market Snapshot: Why GenesisX Matters in Cardiac Care In the dynamic landscape of cardiac surgery, where precision and accessibility often determine patient outcomes, a groundbreaking development has emerged to reshape market dynamics and improve lives. Stereotaxis, a leading medical technology

Every year, millions of women face the challenges of menopause, grappling with symptoms like hot flashes and night sweats that can disrupt daily life, and for decades, hormone replacement therapy (HRT) has been a potential lifeline, yet shrouded in fear due to severe FDA warnings linking it to

The United States finds itself at a critical juncture with a historic 41-day government shutdown, the longest in national history, colliding with a heated debate over extending enhanced Affordable Care Act (ACA) subsidies. This dual crisis has left millions of Americans grappling with halted

I'm thrilled to sit down with James Maitland, a renowned expert in healthcare policy and antitrust regulation with a deep understanding of how hospital mergers impact communities and markets. With years of experience analyzing the intersection of healthcare access, pricing, and competition, James